Literature DB >> 22924280

Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.

Daniel Azmeraw1, Belaynew Wasie.   

Abstract

BACKGROUND: highly active antiretroviral therapy (HAART) results in improved survival, clinical, immunological and virological response for children. Adherence to HAART is one of the very important factors which determine treatment success and occurrence of viral resistance. The need for near perfect adherence to lifelong antiretroviral therapy (ART) during childhood is a major challenge in the administration of HAART to HIV infected children.
OBJECTIVE: the study was aimed to determine the level of adherence and factors associated with adherence to HAART among children in Felege Hiwot and Gondar University referral hospitals.
METHODS: institution based cross-sectional study was conducted on 204 children in the paediatric ART clinics of Gondar University and Felege Hiwot hospitals. Sample size was determined by single population proportion formula and all children on ART for > or = 1 month and coming to the clinic during the data collection period were studied Ethical clearance was obtained from the Institutional Review Board of the University of Gondar. Data were collected by four nurses from the caregivers and patient charts using a pretested and structured questionnaire after informed consent. Descriptive statistics were calculated to describe study population and medical characteristics of participants while binary and multiple logistic regression analyses were used to determine the effect of factors on the outcome variable.
RESULTS: The study included 204 children (123 from Flege Hiwot and 81 from Gondar). One hundred and seven (52.4%) were males and 97(47.6%) were females. Majority (82.4%) of caregivers were females. Thirty days optimum (> or = 95%) adherence rate was 80.9% for children. Adherence counseling before initiation (OR=4.37, 95%CI 1.17 - 16.37), caregiver formal education, (OR=4.85, 95%CI 1.89 - 12.39) and caregiver's ability to identify ARV drug correctly (OR = 8.61, 95%CI 2.59-28.68) were positively associated while care giver substance use (OR=0.31, 95%CI 0.10 - 0.93) was negatively associated with adherence as compared to their counter parts.
CONCLUSION: optimum adherence rate to HAART in the study population was lower than the recommended Adherence counseling, caregiver education, substance use by caregiver, identification of ARVs determined adherence to HAART of children. Adherence assessment and counseling efforts should be continually integrated with ART for children and their caregivers.

Entities:  

Mesh:

Year:  2012        PMID: 22924280

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  11 in total

1.  Adherence to HIV Antiretroviral Therapy Among Pregnant and Breastfeeding Women, Non-Pregnant Women, and Men in Burkina Faso: Nationwide Analysis 2019-2020.

Authors:  Wedminere Noëlie Zoungrana-Yameogo; Lucresse Corine Fassinou; Calypse Ngwasiri; Sekou Samadoulougou; Isidore Tiandiogo Traoré; Hervé Hien; Fidèle Bakiono; Maxime Drabo; Fati Kirakoya-Samadoulougou
Journal:  Patient Prefer Adherence       Date:  2022-04-13       Impact factor: 2.314

2.  Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia.

Authors:  Kesetebirhan Delele Yirdaw; Susan Hattingh
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

3.  Adherence to highly active antiretroviral therapy and associated factors among children at the University of Gondar Hospital and Gondar Poly Clinic, Northwest Ethiopia: a cross-sectional institutional based study.

Authors:  Berihun Assefa Dachew; Tadis Brhane Tesfahunegn; Anteneh Messele Birhanu
Journal:  BMC Public Health       Date:  2014-08-26       Impact factor: 3.295

4.  Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

Authors:  Philippe R Mutwa; Kimberly R Boer; Brenda Asiimwe-Kateera; Diane Tuyishimire; Narcisse Muganga; Joep M A Lange; Janneke van de Wijgert; Anita Asiimwe; Peter Reiss; Sibyl P M Geelen
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

5.  Adherence to antiretroviral treatment among children and adolescents in Tanzania: Comparison between pill count and viral load outcomes in a rural context of Mwanza region.

Authors:  Giulia Martelli; Rosa Antonucci; Alphonsina Mukurasi; Henry Zepherine; Christiana Nöstlinger
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

6.  [Factors associated with non-adherence of adults infected with HIV on antiretroviral therapy in a referral hospital in Douala].

Authors:  Emmanuel Noel Essomba; Dieudonné Adiogo; Danielle Christiane Kedy Koum; Baudouin Amang; Leopold Gustave Lehman; Yves Coppieters
Journal:  Pan Afr Med J       Date:  2015-04-27

7.  Who takes the medicine? Adherence to antiretroviral therapy in Southern Ethiopia.

Authors:  Wondu Teshome; Mihretu Belayneh; Mathewos Moges; Misganu Endriyas; Emebet Mekonnen; Sinafiksh Ayele; Tebeje Misganaw; Mekonnen Shiferaw; Palanivel Chinnakali; Sven Gudmund Hinderaker; Ajay Mv Kumar
Journal:  Patient Prefer Adherence       Date:  2015-10-29       Impact factor: 2.711

8.  Adherence to antiretroviral therapy and its associated factors among children at South Wollo Zone Hospitals, Northeast Ethiopia: a cross-sectional study.

Authors:  Getachew Arage; Gizachew Assefa Tessema; Hiwot Kassa
Journal:  BMC Public Health       Date:  2014-04-15       Impact factor: 3.295

Review 9.  Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations.

Authors:  Simona A Iacob; Diana G Iacob; Gheorghita Jugulete
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810

Review 10.  Adherence to Highly Active Antiretroviral Therapy Among Children in Ethiopia: A Systematic Review and Meta-analysis.

Authors:  Aklilu Endalamaw; Nega Tezera; Setegn Eshetie; Sintayehu Ambachew; Tesfa Dejenie Habtewold
Journal:  AIDS Behav       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.